Wegovy maker warns of 'painful' price cuts as shares plunge
Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
